A new bionic knee that connects directly to bones and muscles may help above-the-knee amputees walk and climb more easily.

The American Journal of Managed Care provides insights into the latest news and research in managed care across multimedia ...

Traditionally, drug discovery relied heavily on trial and error, with long timelines and high costs. The introduction of ...

In an industry where 90 percent of drug candidates fail before reaching the market, a handful of startups are betting ...

Since its introduction in 2015, the global action plan (GAP) on antimicrobial resistance (AMR) has guided the global response to AMR1 and the development of 178 national action plans (NAPs). However, ...

Seven biotech unicorns are advancing AI-powered drug discovery and development—but must contend with a difficult investing ...

The Silicon Valley entrepreneur has turned his body into a living experiment in a bid to reframe longevity as a solvable ...

The era of predictive modeling enhanced with machine learning and artificial intelligence (AI) to aid clinical ...

The next generation of deep-brain stimulation automatically corrects the precise brain waves that create symptoms of ...

Progress towards The Lancet Commission on Global Surgery's 2030 targets has been too slow and too patchy, particularly in low ...

One of the biggest barriers to the adoption of any new biotechnology tool is validation and regulatory clarity.

Glenmark’s progress with a cancer treatment shows the potential of Indian pharma to move from generics to drug discovery. With tech-enabled therapies evolving fast, new inflection points spell a ...